Hello, my name is Janet Pope and I am a rheumatologist in Canada with a specific interest in scleroderma, especially clinical trials and clinical research studies. I am an Associate Professor of the Department of Medicine, Division of Rheumatology and Epidemiology and Biostatistics at the University of Western Ontario, London, Ontario, Canada.
I obtained my MD and Fellowship in Internal Medicine at the University of Western Ontario. I acquired a Fellowship in Rheumatology and Masters of Public Health at Boston University. I completed a Canadian Arthritis Society Research Fellowship In London, Ontario in scleroderma, and then became a member of the Division of Rheumatology. I am currently Program Director in Rheumatology, sit on five Advisory Boards, and am member of the Scleroderma Clinical Trials Consortium.
I have published over fifty research articles pertaining to rheumatic diseases. I look forward to sharing my expertise in this field. My email address is [email protected].
Treatment of Systemic Sclerosis Complications. What to use when first-line treatment fails; a consensus of systemic sclerosis experts. Symptoms treatment recommendations by over 100 scleroderma experts, for scleroderma renal crisis (SRC), digital ulcers (DU), pulmonary hypertension (PAH/PH), reflux, skin involvement, and arthritis. Seminars in Arthritis and Rheumatism Volume 42, Issue 1 , Pages 42-55, August 2012. (Also see Scleroderma Renal Crisis, Digital Ulcers, Pulmonary Hypertension, Reflux, Skin Involvement, Skeletal Involvement, and Scleroderma Treatments)
ISN Liaison to Medical Advisory Board
Medical Advisory Board Members
|Foster, C. Stephen||U.S.|
|Van den Hoogen, Frank*||Netherlands|
|* = Need ISN Profile Submitted|
Prevalence of Elevated Pulmonary Arterial Pressures Measured by Echocardiography in a Multicenter Study of Patients with Systemic Sclerosis. Elevated pulmonary arterial pressures (PAP) are common in both limited and diffuse SSc disease, occurring in 21% of limited and 26% of diffuse SSc patients. A high index of suspicion is important and routine echocardiography in symptomatic patients may allow earlier diagnosis of PAH and intervention. J Rheumatol. 2005 July;32:1273-8. (Also see Pulmonary Hypertension, Limited Scleroderma, and Diffuse Scleroderma)
Kym: Diffuse, CREST Scleroderma, Lupus and Fibromyalgia It all started with Raynaud's in my fingers and toes when I was about nineteen years old, in 1979…
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: